Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

Paggiaro PL, Dahle R, Bakran I, Frith L, Hollingworth K, Efthimiou J.

Lancet. 1998 Mar 14;351(9105):773-80. Erratum in: Lancet 1998 Jun 27;351(9120):1968.

PMID:
9519948
2.
3.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
5.
6.

[Corticosteroid therapy of non-asthmatic chronic obstructive bronchopneumopathies].

Jébrak G, Pichot-Vérité MH, Marceau A, Rullon I.

Presse Med. 2000 Sep 16;29(16):1479-87. Review. French.

PMID:
11039096
7.

A randomised, double-blind, placebo-controlled study to evaluate the efficacy of oral azithromycin as a supplement to standard care for adult patients with acute exacerbations of asthma (the AZALEA trial).

Johnston SL, Szigeti M, Cross M, Brightling C, Chaudhuri R, Harrison T, Mansur A, Robison L, Sattar Z, Jackson D, Mallia P, Wong E, Corrigan C, Higgins B, Ind P, Singh D, Thomson N, Ashby D, Chauhan A.

Southampton (UK): NIHR Journals Library; 2016 Oct.

8.

Role of antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease.

Russo RL, D'Aprile M.

Ann Pharmacother. 2001 May;35(5):576-81. Review.

PMID:
11346065
9.

Case report and review of esophageal lichen planus treated with fluticasone.

Ynson ML, Forouhar F, Vaziri H.

World J Gastroenterol. 2013 Mar 14;19(10):1652-6. doi: 10.3748/wjg.v19.i10.1652. Review.

10.

Mucoactive drugs in the management of chronic obstructive pulmonary disease.

Del Donno M, Olivieri D.

Monaldi Arch Chest Dis. 1998 Dec;53(6):714-9. Review.

PMID:
10063352
11.

Airway obstruction in severe COPD.

Wilson AF.

Chest. 2000 Oct;118(4):889-91. Review. No abstract available.

PMID:
11035650
12.

Chronic obstructive pulmonary disease. Current concepts and therapeutic approaches.

Gross NJ.

Chest. 1990 Feb;97(2 Suppl):19S-23S. Review.

PMID:
2404708
13.

Different approaches in the treatment of obstructive pulmonary diseases.

Kabir ER, Morshed N.

Eur J Pharmacol. 2015 Oct 5;764:306-17. doi: 10.1016/j.ejphar.2015.07.030. Epub 2015 Jul 11. Review.

PMID:
26172082
14.

Assessment end points for inhaled drug delivery.

Anderson PJ.

Respir Care. 2000 Jun;45(6):737-55. Review.

PMID:
10894464
15.

Systemic corticosteroids for chronic obstructive pulmonary disease: benefits and risks.

Niewoehner DE.

Monaldi Arch Chest Dis. 1999 Oct;54(5):422-6. Review.

PMID:
10741103
16.

COPD: the scope of the problem in Europe.

Pauwels R.

Chest. 2000 May;117(5 Suppl 2):332S-5S. Review.

PMID:
10843972
17.

Chronic obstructive pulmonary disease--can we do better?

Petty TL.

Chest. 1990 Feb;97(2 Suppl):2S-5S. Review.

PMID:
2404709

Supplemental Content

Support Center